SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Furuzawa-Carballeda J.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:42
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Increased dietary protein stimulates amino acid catabolism via the gut microbiota and secondary bile acid production (2025)
 
2.- Achalasia alters physiological networks depending on sex (2024)
 
3.- Prolactin Inhibits or Stimulates the Inflammatory Response of Joint Tissues in a Cytokine-dependent Manner (2023)
 
4.- Long-term follow-up of Covid-19 treatment with polymerized type i collagen: Modifications to the physiological network (2023)
 
5.- Assessment of the Relationship Between Inflammation and Glomerular Filtration Rate (2023)
 
6.- Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia? (2023)
 
7.- Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis (2023)
 
8.- A Higher Manometric Esophageal Length to Height Ratio in Achalasia Explains the Lower Prevalence of Hiatal Hernia (2023)
 
9.- Predictive factors associated with the persistence of chest pain in post-laparoscopic myotomy and fundoplication in patients with achalasia (2022)
 
10.- Autoantigen characterization in the lower esophageal sphincter muscle of patients with achalasia (2022)
 
11.- Intestinal production of secreted protein acidic and rich in cysteine (SPARC) in patients with ulcerative colitis (2021)
 
12.- Increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and MMP10, MMP23 in inflammatory bowel disease: Cross-sectional study (2021)
 
13.- AKAP12/Gravin is over-expressed in patients with ulcerative colitis (2021)
 
14.- Expression of TOB/BTG family members in patients with inflammatory bowel disease (2021)
 
15.- Does laparoscopic reoperation yield symptomatic improvements similar to those of primary laparoscopic Heller myotomy in achalasia patients? (2021)
 
16.- Triosephosphate isomerase, carbonic anhydrase, and creatinine kinase-brain isoform are possible antigen targets in patients with achalasia (2020)
 
17.- Goat?s milk intake prevents obesity, hepatic steatosis and insulin resistance in mice fed a high-fat diet by reducing inflammatory markers and increasing energy expenditure and mitochondrial content in skeletal muscle (2020)
 
18.- Esophagogastric junction outflow obstruction: Characterization of a new entity? Clinical, manometric, and neuroimmunological description (2020)
 
19.- Long-Term Effectiveness of Polymerized-Type i Collagen Intra-Articular Injections in Patients with Symptomatic Knee Osteoarthritis: Clinical and Radiographic Evaluation in a Cohort Study (2020)
 
20.- The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes (2019)
 
21.- MicroRNA Expression in Cutaneous Lupus: A New Window to Understand Its Pathogenesis (2019)
 
22.- Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years (2019)
 
23.- Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease (2018)
 
24.- New insights into the pathophysiology of Achalasia and implications for future treatment (2016)
 
25.- Differential Cytokine Expression and Regulatory Cells in Patients with Primary and Secondary Sjögren's Syndrome (2015)
 
26.- Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease (2015)
 
27.- Differential expression of MUC12, MUC16, and MUC20 in patients with active and remission ulcerative colitis (2015)
 
28.- Gene and protein expression of centaurin beta 1 (CENTB1) are up-regulated in patients with ulcerative colitis (2013)
 
29.- Indoleamine 2,3-dioxygenase: Expressing cells in inflammatory bowel disease - A cross-sectional study (2013)
 
30.- Genetic association of CCR5 promoter single nucleotide polymorphism in seronegative and seropositive rheumatoid arthritis (2012)
 
31.- Subcutaneous administration of polymerized type i collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-ß1 expression, and increases Foxp3-expressing cells in localized scleroderma (2012)
 
32.- Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: A cross-sectional study (2012)
 
33.- Expresión de la interleucina (IL-10) con función inmunorreguladora en mucosa de pacientes con colitis ulcerosa crónica idiopática (2011)
 
34.- Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial (2006)
 
35.- Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1ß, TNF-a, TGF-ß1, ELAM-1 and VCAM-1 expression in scleroderma skin lesions (2005)
 
36.- Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial (2003)
 
37.- Cellular and humoral responses to collagen-polyvinylpyrrolidone administered during short and long periods in humans (2003)
 
38.- Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen (2002)
 
39.- Erratum: Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen (Clinical and Experimental Immunology (2002) 130 (140-149)) (2002)
 
40.- Interleukin-8, interleukin- 10, intercellular adhesion molecule- 1 and vascular cell adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis (1999)
 
41.- Collagen-PVP decreases collagen turnover in synovial tissue cultures from rheumatoid arthritis patients (1999)
 
42.- Long-term risk of adult overweight and obesity among achalasia patients who underwent Heller Myotomy ()
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.